SOURCE: The Mattson Jack Group, Inc.

May 07, 2008 11:28 ET

MattsonJack Announces Cooperative Agreement With LifeScience Consulting Group International AG

ST. LOUIS, MO and KARLSRUHE, GERMANY--(Marketwire - May 7, 2008) - Richard Martin, President and Chief Operating Officer for The Mattson Jack Group, Inc. (MattsonJack), announced that LifeScience Consulting Group International AG (LCG) of Karlsruhe, Germany, has become a member of MattsonJack International.

Founded in 1994, LCG is one of the largest consultancies based in Germany with a specific focus on life sciences. With a broad range of therapeutic expertise, LCG has worked with its clients in the following business areas:

--  Pharmaceutical and biotech
--  Medical technology
--  Venture capital / private equity funding
--  Clinics, hospitals, and physicians
--  Health funds (statutory / company / private), pricing and
--  Government and regulatory agencies

Horst Mertens, M.D., M.B.A., Chief Executive Officer and Senior Partner of LCG, stated, "We are pleased to enter into this agreement with MattsonJack for we expect the synergy between our organizations will provide wonderful insights and value to our clients around the world."

Pierre Anhoury, Senior Vice President and Business Leader of MattsonJack Europe in Paris, said, "Dr. Mertens and the staff of LCG have demonstrated substantial competency over the years serving pharmaceutical and biotech companies. As part of MattsonJack International, together we will be even better positioned to serve clients such as Boehringer Ingelheim, Novartis, Roche, Bayer Schering-Plough, and many others, both large and small, in business decision support."

For information, visit, e-mail Richard W. Martin, President and Chief Operating Officer at or call +(314) 469-7600.

Editor's Notes:


Formed in 1986, MattsonJack focuses its client support in three areas of Competency: Business Analytics, Brand Optimization, and Corporate Development services in the pharmaceutical and biotech markets. MattsonJack consultants have expertise in pricing and reimbursement, custom epidemiology, technology assessment, business and strategic plan development, due diligence and licensing support, market modeling and forecasting, and primary market research. MattsonJack's client list ranges from emerging companies to some of the most recognized pharmaceutical and biotech companies in the world, such as Abbott, Amgen, AstraZeneca, Genentech, GlaxoSmithKline, Guerbet, Johnson & Johnson Companies, Merck, Novartis, Pfizer, Roche, Wyeth, and many others.

MattsonJack's knowledgeware and client productivity tools include Epi Database® and Forecast Architect®. Additionally, MattsonJack, as one of the largest global oncology consulting firms, supports its clients' cancer interests through its MattsonJack DaVinci multiclient offerings, including CancerMPact®, CancerNSight®, Oncology Marketing Strategies™, Supportive Care Perspectives™, Future Focus™ Myelodysplastic Syndromes (MDS) .

MattsonJack is part of Kantar Group, the Information and Consultancy division of WPP, a $10+ billion global communications services firm.


Kantar is one of the world's largest research, insight and consultancy networks. It helps clients make better business decisions through a deeper understanding of their markets, their brands and their customers.

Part of WPP, Kantar brings together a diverse group of outstanding marketing insight and consulting companies -- each an expert in their field who can work together seamlessly to help clients address business issues in a holistic and strategic way.

Companies include: Added Value Group, AMRB, BMRB, BPRI, Cannondale Associates, Center Partners, Everystone, Focalyst, Fusion 5, Glendinning Management Consultants, Henley Centre HeadlightVision, IMRB, Kantar Operations, KMR Group, Lightspeed Research, Management Ventures, The Mattson Jack Group, Millward Brown, Research International, RMS and Ziment Group. The group operates in 160 offices across 60 markets worldwide.

Contact Information